KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Humana (HUM) Asset Writedowns and Impairment (2022 - 2025)

Humana has reported Asset Writedowns and Impairment over the past 4 years, most recently at $221.0 million for Q4 2025.

  • Quarterly results put Asset Writedowns and Impairment at $221.0 million for Q4 2025, up 211.27% from a year ago — trailing twelve months through Dec 2025 was $253.0 million (up 143.27% YoY), and the annual figure for FY2025 was $253.0 million, up 26.5%.
  • Asset Writedowns and Impairment for Q4 2025 was $221.0 million at Humana, up from -$9.0 million in the prior quarter.
  • Over the last five years, Asset Writedowns and Impairment for HUM hit a ceiling of $221.0 million in Q4 2025 and a floor of -$9.0 million in Q3 2025.
  • Median Asset Writedowns and Impairment over the past 4 years was $32.5 million (2024), compared with a mean of $67.1 million.
  • Biggest five-year swings in Asset Writedowns and Impairment: skyrocketed 675.0% in 2023 and later tumbled 72.73% in 2025.
  • Humana's Asset Writedowns and Impairment stood at $104.0 million in 2022, then soared by 68.27% to $175.0 million in 2023, then crashed by 59.43% to $71.0 million in 2024, then surged by 211.27% to $221.0 million in 2025.
  • The last three reported values for Asset Writedowns and Impairment were $221.0 million (Q4 2025), -$9.0 million (Q3 2025), and $32.0 million (Q2 2025) per Business Quant data.